دورية أكاديمية

Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis

التفاصيل البيبلوغرافية
العنوان: Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis
المؤلفون: Kondo, MasahiroAff1, IDs13075022028993_cor1, Suzuki, Tsuyoshi, Kawano, Yuko, Kojima, Shinji, Miyashiro, Masahiko, Matsumoto, Atsuhiro, Kania, Gabriela, Błyszczuk, Przemysław, Ross, Rebecca L.Aff3, Aff4, Mulipa, PanjiAff3, Aff4, Del Galdo, FrancescoAff3, Aff4, Zhang, Yun, Distler, Jörg H. W.
المصدر: Arthritis Research & Therapy. 24(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14786362
DOI:10.1186/s13075-022-02899-3